{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:53:46Z","timestamp":1791140026992,"version":"4.1.0"},"reference-count":44,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Low-risk myelodysplastic syndromes (MDS), including refractory anemia and sideroblastic anemia, are characterized by increased apoptotic death of erythroid progenitors. The signaling pathways that elicit this pathologic cell death in MDS have, however, remained unclear. Treatment with erythropoietin in combination with granulocyte colony-stimulating factor (G-CSF) may synergistically improve the anemia in patients with MDS, with a concomitant decrease in the number of apoptotic bone marrow precursors. Moreover, we have previously reported that G-CSF inhibits Fas-induced caspase activation in sideroblastic anemia (RARS). The present data demonstrate that almost 50% of erythroid progenitor cells derived from patients with MDS exhibit spontaneous release of cytochrome c from mitochondria with ensuing activation of caspase-9, whereas normal erythroid progenitors display neither of these features. G-CSF significantly inhibited cytochrome c release and suppressed apoptosis, most noticeably in cells from patients with sideroblastic anemia. Furthermore, inhibition of caspase-9 suppressed both spontaneous and Fas-mediated apoptosis of erythroid progenitors in all low-risk MDS cases studied. We propose that the increased sensitivity of MDS progenitor cells to death receptor stimulation is due to a constitutive activation of the mitochondrial axis of the apoptotic signaling pathway in these cells. These studies yield a mechanistic explanation for the beneficial clinical effects of growth factor administration in patients with MDS, and provide a model for the study of growth factor\u2013mediated suppression of apoptosis in other bone marrow disorders.<\/jats:p>","DOI":"10.1182\/blood-2002-06-1774","type":"journal-article","created":{"date-parts":[[2003,1,15]],"date-time":"2003-01-15T16:05:10Z","timestamp":1042646710000},"page":"1080-1086","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":107,"title":["Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors"],"prefix":"10.1182","volume":"101","author":[{"given":"Ramin","family":"Tehranchi","sequence":"first","affiliation":[{"name":"From the Department of Medicine, Division of Hematology, and the Department of Pathology, Huddinge University Hospital; the Institute of Environmental Medicine, Division of Toxicology; and the Department of Medicine, Southern Hospital, Karolinska Institutet, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Fadeel","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Division of Hematology, and the Department of Pathology, Huddinge University Hospital; the Institute of Environmental Medicine, Division of Toxicology; and the Department of Medicine, Southern Hospital, Karolinska Institutet, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Mari","family":"Forsblom","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Division of Hematology, and the Department of Pathology, Huddinge University Hospital; the Institute of Environmental Medicine, Division of Toxicology; and the Department of Medicine, Southern Hospital, Karolinska Institutet, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birger","family":"Christensson","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Division of Hematology, and the Department of Pathology, Huddinge University Hospital; the Institute of Environmental Medicine, Division of Toxicology; and the Department of Medicine, Southern Hospital, Karolinska Institutet, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Samuelsson","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Division of Hematology, and the Department of Pathology, Huddinge University Hospital; the Institute of Environmental Medicine, Division of Toxicology; and the Department of Medicine, Southern Hospital, Karolinska Institutet, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Zhivotovsky","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Division of Hematology, and the Department of Pathology, Huddinge University Hospital; the Institute of Environmental Medicine, Division of Toxicology; and the Department of Medicine, Southern Hospital, Karolinska Institutet, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Hellstrom-Lindberg","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Division of Hematology, and the Department of Pathology, Huddinge University Hospital; the Institute of Environmental Medicine, Division of Toxicology; and the Department of Medicine, Southern Hospital, Karolinska Institutet, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111611373726200_B1","first-page":"71","article-title":"Pathogenesis, etiology and epidemiology of myelodysplastic syndromes.","volume":"83","author":"Aul","year":"1998","journal-title":"Haematologica."},{"key":"2019111611373726200_B2","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes.","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood."},{"key":"2019111611373726200_B3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1182\/blood.V86.1.268.bloodjournal861268","article-title":"Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes.","volume":"86","author":"Raza","year":"1995","journal-title":"Blood."},{"key":"2019111611373726200_B4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0145-2126(96)00110-5","article-title":"Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin.","volume":"21","author":"Hellstrom-Lindberg","year":"1997","journal-title":"Leuk Res."},{"key":"2019111611373726200_B5","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1046\/j.1365-2141.1998.01114.x","article-title":"\u2018Low-risk\u2019 myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro- versus anti-apoptotic bcl-2-related proteins.","volume":"103","author":"Parker","year":"1998","journal-title":"Br J Haematol."},{"key":"2019111611373726200_B6","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1182\/blood.V88.3.1122b.1122b","article-title":"Fas (CD95) receptor and Fas-ligand expression in bone marrow cells from patients with myelodysplastic syndrome.","volume":"88","author":"Gersuk","year":"1996","journal-title":"Blood."},{"key":"2019111611373726200_B7","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/sj.leu.2400654","article-title":"Fas\/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.","volume":"11","author":"Bouscary","year":"1997","journal-title":"Leukemia."},{"key":"2019111611373726200_B8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/10428199809057543","article-title":"Fas\/APO-1 (CD95) expression in myelodysplastic syndromes.","volume":"30","author":"Lepelley","year":"1998","journal-title":"Leuk Lymphoma."},{"key":"2019111611373726200_B9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1365-2141.1998.00933.x","article-title":"A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome.","volume":"103","author":"Gersuk","year":"1998","journal-title":"Br J Haematol."},{"key":"2019111611373726200_B10","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","article-title":"Mitochondria and apoptosis.","volume":"281","author":"Green","year":"1998","journal-title":"Science."},{"key":"2019111611373726200_B11","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/35037710","article-title":"The biochemistry of apoptosis.","volume":"407","author":"Hengartner","year":"2000","journal-title":"Nature."},{"key":"2019111611373726200_B12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2141.1999.01310.x","article-title":"Significance of electron-dense deposits in the mitochondrial matrix of erythroid precursors in aplastic anaemia and myelodysplastic syndrome.","volume":"105","author":"Bessho","year":"1999","journal-title":"Br J Haematol."},{"key":"2019111611373726200_B13","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1182\/blood.V90.12.4961","article-title":"Heteroplasmic point mutations of mitochondrial DNA affecting subunit I of cytochrome c oxidase in two patients with acquired idiopathic sideroblastic anemia.","volume":"90","author":"Gattermann","year":"1997","journal-title":"Blood."},{"key":"2019111611373726200_B14","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1046\/j.0007-1048.2001.03323.x","article-title":"Increased incidence of mitochondrial cytochrome c-oxidase gene mutations in patients with myelodysplastic syndromes.","volume":"116","author":"Reddy","year":"2002","journal-title":"Br J Haematol."},{"key":"2019111611373726200_B15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1182\/blood.V92.1.68.413k23_68_75","article-title":"Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patients.","volume":"92","author":"Hellstrom-Lindberg","year":"1998","journal-title":"Blood."},{"key":"2019111611373726200_B16","first-page":"1058","article-title":"Erythropoietin plus granulocyte colony-stimulating factor in the treatment of myelodysplastic syndromes. Identification of a subgroup of responders. The Spanish Erythropathology Group.","volume":"84","author":"Remacha","year":"1999","journal-title":"Haematologica."},{"key":"2019111611373726200_B17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1365-2141.2000.02016.x","article-title":"Treatment of anaemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony-stimulating factor and erythropoietin.","volume":"109","author":"Mantovani","year":"2000","journal-title":"Br J Haematol."},{"key":"2019111611373726200_B18","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/sj.leu.2402110","article-title":"Granulocyte colony-stimulating factor inhibits Fas-triggered apoptosis in bone marrow cells isolated from patients with refractory anemia with ringed sideroblasts.","volume":"15","author":"Schmidt-Mende","year":"2001","journal-title":"Leukemia."},{"key":"2019111611373726200_B19","volume-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues.","author":"Jaffe","year":"2001"},{"key":"2019111611373726200_B20","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1046\/j.1365-2141.2001.02581.x","article-title":"Apoptosis in refractory anaemia with ringed sideroblasts is initiated at the stem cell level and associated with increased activation of caspases.","volume":"112","author":"Hellstrom-Lindberg","year":"2001","journal-title":"Br J Haematol."},{"key":"2019111611373726200_B21","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1046\/j.1365-2141.1999.01639.x","article-title":"Purification, amplification and characterization of a population of human erythroid progenitors.","volume":"106","author":"Freyssinier","year":"1999","journal-title":"Br J Haematol."},{"key":"2019111611373726200_B22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/376037a0","article-title":"Identification and inhibition of the ICE\/CED-3 protease necessary for mammalian apoptosis.","volume":"376","author":"Nicholson","year":"1995","journal-title":"Nature."},{"key":"2019111611373726200_B23","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1038\/sj.onc.1204402","article-title":"Defective caspase-3 relocalization in non-small cell lung carcinoma.","volume":"20","author":"Joseph","year":"2001","journal-title":"Oncogene."},{"key":"2019111611373726200_B24","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/sj.leu.2401871","article-title":"The most unkindest cut of all: on the multiple roles of mammalian caspases.","volume":"14","author":"Fadeel","year":"2000","journal-title":"Leukemia."},{"key":"2019111611373726200_B25","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1046\/j.1365-2141.1997.4013211.x","article-title":"Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model.","volume":"99","author":"Hellstrom-Lindberg","year":"1997","journal-title":"Br J Haematol."},{"key":"2019111611373726200_B26","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1182\/blood.V99.5.1594","article-title":"In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis.","volume":"99","author":"Claessens","year":"2002","journal-title":"Blood."},{"key":"2019111611373726200_B27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2141.1995.tb05277.x","article-title":"Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia.","volume":"91","author":"Maciejewski","year":"1995","journal-title":"Br J Haematol."},{"key":"2019111611373726200_B28","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0092-8674(00)81590-1","article-title":"Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis.","volume":"94","author":"Li","year":"1998","journal-title":"Cell."},{"key":"2019111611373726200_B29","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0092-8674(00)81589-5","article-title":"Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors.","volume":"94","author":"Luo","year":"1998","journal-title":"Cell."},{"key":"2019111611373726200_B30","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/23730","article-title":"Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis.","volume":"400","author":"Yin","year":"1999","journal-title":"Nature."},{"key":"2019111611373726200_B31","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/emboj\/17.6.1675","article-title":"Two CD95 (APO-1\/Fas) signaling pathways.","volume":"17","author":"Scaffidi","year":"1998","journal-title":"Embo J."},{"key":"2019111611373726200_B32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes.","volume":"51","author":"Bennett","year":"1982","journal-title":"Br J Haematol."},{"key":"2019111611373726200_B33","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1136\/jcp.36.5.566","article-title":"Prevalence and distribution of ringed sideroblasts in primary myelodysplastic syndromes.","volume":"36","author":"Juneja","year":"1983","journal-title":"J Clin Pathol."},{"key":"2019111611373726200_B34","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1365-2141.1982.tb03937.x","article-title":"Erythroblast iron metabolism in sideroblastic marrows.","volume":"52","author":"May","year":"1982","journal-title":"Br J Haematol."},{"key":"2019111611373726200_B35","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/343076a0","article-title":"Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis.","volume":"343","author":"Williams","year":"1990","journal-title":"Nature."},{"key":"2019111611373726200_B36","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1182\/blood.V80.8.2012.2012","article-title":"Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products.","volume":"80","author":"Colotta","year":"1992","journal-title":"Blood."},{"key":"2019111611373726200_B37","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1182\/blood.V80.11.2920.2920","article-title":"Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death.","volume":"80","author":"Brach","year":"1992","journal-title":"Blood."},{"key":"2019111611373726200_B38","doi-asserted-by":"crossref","first-page":"13330","DOI":"10.1073\/pnas.96.23.13330","article-title":"Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: a general mechanism to accumulate effector cells in inflammation.","volume":"96","author":"Dibbert","year":"1999","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111611373726200_B39","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1182\/blood.V99.2.672","article-title":"Granulocyte colony-stimulating factor inhibits the mitochondria-dependent activation of caspase-3 in neutrophils.","volume":"99","author":"Maianski","year":"2002","journal-title":"Blood."},{"key":"2019111611373726200_B40","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1182\/blood.V98.7.2239","article-title":"Interleukin-5 inhibits translocation of Bax to the mitochondria, cytochrome c release, and activation of caspases in human eosinophils.","volume":"98","author":"Dewson","year":"2001","journal-title":"Blood."},{"key":"2019111611373726200_B41","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1084\/jem.192.5.647","article-title":"Fas ligand, Bcl-2, granulocyte colony-stimulating factor, and p38 mitogen-activated protein kinase: regulators of distinct cell death and survival pathways in granulocytes.","volume":"192","author":"Villunger","year":"2000","journal-title":"J Exp Med."},{"key":"2019111611373726200_B42","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/(SICI)1096-8652(199901)60:1<36::AID-AJH7>3.0.CO;2-#","article-title":"Evidence for involvement of tumor necrosis factor-alpha in apoptotic death of bone marrow cells in myelodysplastic syndromes.","volume":"60","author":"Mundle","year":"1999","journal-title":"Am J Hematol."},{"key":"2019111611373726200_B43","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1182\/blood.V98.10.3058","article-title":"Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis.","volume":"98","author":"Zang","year":"2001","journal-title":"Blood."},{"key":"2019111611373726200_B44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/sj.leu.2402338","article-title":"TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors.","volume":"16","author":"Plasilova","year":"2002","journal-title":"Leukemia."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/3\/1080\/1260972\/h80303001080.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/3\/1080\/1260972\/h80303001080.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T11:37:51Z","timestamp":1573904271000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/101\/3\/1080\/88872\/Granulocyte-colonystimulating-factor-inhibits"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2,1]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,2,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-06-1774","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2003,2,1]]}}}